Difference between revisions of "Abiraterone"
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
==See also== | ==See also== | ||
*[[Enzalutamide]]. | |||
*[[Prostate cancer]]. | *[[Prostate cancer]]. | ||
Revision as of 03:03, 20 May 2016
Abiraterone is an androgen synthesis inhibitor used to treat prostate cancer.[1]
See also
References
- ↑ Mitsiades, N. (Aug 2013). "A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer.". Cancer Res 73 (15): 4599-605. doi:10.1158/0008-5472.CAN-12-4414. PMID 23887973.